Логин: Пароль: ?
 
Продукты питания Ткань, одежда, обувь, постельное белье, текстиль Строительные материалы Бумага, пластик, промтовары Биотопливо Продукция для сельского хозяйства, зоотовары Косметика, средства гигиены Медицинские товары и препараты, лекарства Иное

 

 

 

 

 

 

 

Новости/Аналитика

Great Britain officially recognized cannabidiol as a medicine

11.10.2016

Logo MHRA
It is necessary not only to amend the existing legislation, according to which at the legislative level to distinguish between technical and medical cannabis, but also to initiate a process aimed at creating conditions in which the therapeutic properties of cannabis to be used for medical purposes.
 
The Executive Department of Health Authority of the United Kingdom, Agency for Medicines and Healthcare products Regulatory (Medicines and Healthcare products Regulatory Agency, MHRA) reported the UK media means that recognizes the therapeutic properties of cannabis.
 
Officials agency reported that one of the cannabinoids contained in cannabis - cannabidiol, has regenerating, regulating, and modifying effects on the body are not only mammals but also human.
 
According to analysts of medical cannabis market, this kind of statement the country's civil servants could be an important step in changing the structures of the UK government against the possibility of the use of cannabis for medical purposes. In addition, such statements shows the mechanism used in democratic countries to lobby for the adoption of legal acts aimed at the development of national konoplevodstva, including in the field of medical use of cannabis.
 
 
Experience in pharmaceutical and healthcare companies, engaged in promotion to the English market of medical cannabis indicates that the competent lobbying in developed countries is gradually changing the attitude of government officials not only to the very problems konoplevodstva, but also to the possibility of using the therapeutic properties of cannabis for the treatment of some heavy, in including chronic diseases. Such information "presence" in the field of relevant government agencies of the country has led to the impossibility of identifying the technical hemp narcotic drugs or psychotropic drugs. In this regard, it is necessary not only to amend the existing legislation, according to which at the legislative level to distinguish between technical and medical cannabis, but also to initiate a process aimed at creating conditions in which the therapeutic properties of cannabis to be used for medical purposes.
Источник фото: 
Потенциал национального рынка каннабиноидных косметических препаратов
17.01.2024

В Украине потребитель готов для выведения на рынок линейки национальной профессиональной CBD косметической продукции

Объявления
Все объявления »
 
 

facebook

telegram

twitter